Home / Market News / $TLRY

$TLRY news and market catalysts

The 13 most recent market catalysts affecting $TLRY, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

13 catalysts 5 high impact 6 bullish 3 bearish Cannabis
Nov 3, 2026 Corporate Catalyst Bullish Impact 75
Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Raise Fiscal 2027 EBITDA Guidance
Tilray Brands announced a strategic consolidation of its Canadian cannabis operations, moving cultivation and pre-roll production to more efficient facilities. This move is project…
Nov 2, 2026 Corporate Catalyst Neutral Impact 65
Tilray Brands Announces Consolidation of Canadian Cannabis Operations
Tilray Brands announced a strategic consolidation of its Canadian cannabis operations, specifically moving cultivation and pre-roll production from its Foss facility to its Masson …
Oct 29, 2026 Corporate Catalyst Bullish Impact 65
Tilray Brands Announces Operational Efficiency Initiatives for U.S. Beverage Business
Tilray Brands announced a strategic consolidation of its U.S. brewing footprint, reducing its facilities from ten to six. This move is aimed at decreasing complexity and improving …
Oct 27, 2026 Corporate Catalyst Neutral Impact 55
Roth Capital Partners Maintains Buy Rating on Tilray Brands
Roth Capital Partners maintained a 'Buy' rating on Tilray Brands (TLRY) with a US$9.00 price target, primarily due to an expected recovery in earnings. The filing reveals that Tilr…
Oct 19, 2026 Corporate Catalyst Bullish Impact 85
Tilray’s Q1 Results Show A Company Transformed
Tilray's Q1 fiscal 2027 results mark a significant transformation, with record revenue and gross profit driven by its beverage segment, which now surpasses cannabis as the largest …
Oct 13, 2026 Corporate Catalyst Neutral Impact 55
Tilray Brands’ Unit Tilray Medical Secures Key Regulatory Approval For In-House Testing At Portugal Facility
Tilray Medical, a division of Tilray Brands, announced that its EU-GMP-certified facility in Cantanhede, Portugal, has received approval from INFARMED (Portugal's National Authorit…
Oct 8, 2026 Corporate Catalyst Bullish Impact 75
Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines
Tilray Brands released its Q1 2027 earnings, reporting an adjusted loss of 2 cents per share, which beat consensus estimates. However, sales of $257.147 million missed Wall Street …
Oct 8, 2026 Corporate Catalyst Bearish Impact 92
Tilray Brands Q1 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $257.147M Miss $267.813M Estimate
Tilray Brands announced its Q1 earnings, revealing a substantial beat on adjusted EPS but a miss on revenue expectations. The EPS beat by 90% is a positive signal regarding cost co…
Oct 8, 2026 Corporate Catalyst Bearish Impact 85
Tilray Brands Q1 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $257.147M Miss $267.464M Estimate
Tilray Brands announced its Q1 earnings, revealing an adjusted EPS of $(0.02), which was a significant beat compared to the analyst estimate of $(0.20). This suggests better cost m…
Aug 20, 2026 Corporate Catalyst Bullish Impact 65
Tilray Brands Launches Major Expansion Of Its Global Cannabis Cultivation Capacity To Meet Accelerating International Medical Cannabis Demand
Tilray Brands has announced a major expansion of its global cannabis cultivation capacity, including a 30 metric tonne increase at its Quebec facility and enhanced output in Portug…
Aug 3, 2026 Market Technicals Neutral Impact 55
6 Health Care Stocks Whale Activity In Today’s Session
This 8-K filing, presented as a 'whale alert,' tracks significant options activity for six healthcare stocks: TLRY, A, NVO, UNH, REGN, and LLY. It's important because large options…
Jul 29, 2026 Corporate Catalyst Bullish Impact 85
Tilray Brands (TLRY) Stock Is Trending: Here's What You Should Know
Tilray Brands (TLRY) reported mixed Q4 results, with revenue exceeding analyst estimates but EPS falling short. However, the company highlighted record revenue, gross profit, and a…
Jul 28, 2026 Corporate Catalyst Bearish Impact 92
Tilray Brands Q4 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $281.714M Beat $246.377M Estimate
Tilray Brands' Q4 earnings report shows a significant beat on both adjusted EPS and sales estimates. This indicates stronger-than-expected operational performance and revenue gener…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.